155 related articles for article (PubMed ID: 29783529)
1. Conference Scene: Personalized Medicine in Europe.
Greenberg T
Per Med; 2011 May; 8(3):317-319. PubMed ID: 29783529
[TBL] [Abstract][Full Text] [Related]
2. Conference scene: Select Biosciences Epigenetics Europe 2010.
Razvi ES
Epigenomics; 2011 Feb; 3(1):15-8. PubMed ID: 22126149
[TBL] [Abstract][Full Text] [Related]
3. The current and future state of companion diagnostics.
Agarwal A; Ressler D; Snyder G
Pharmgenomics Pers Med; 2015; 8():99-110. PubMed ID: 25897259
[TBL] [Abstract][Full Text] [Related]
4. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
5. The Regulation of Companion Diagnostics: A Global Perspective.
Ansari M
Ther Innov Regul Sci; 2013 Jul; 47(4):405-415. PubMed ID: 30235516
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutical industry perspectives on the business prospects for personalized medicine.
Milne CP; Zuckerman R
Per Med; 2011 Sep; 8(5):541-550. PubMed ID: 29793252
[TBL] [Abstract][Full Text] [Related]
7. The future of biotechnology in Europe.
Hüls C; Müllner S
Arzneimittelforschung; 1997 Feb; 47(2):233-6. PubMed ID: 9079244
[TBL] [Abstract][Full Text] [Related]
8. Chase H&Q--18th Annual Healthcare Conference. 10-13 January 2000, San Francisco, CA, USA.
Hookes J
IDrugs; 2000 Apr; 3(4):398-404. PubMed ID: 16100695
[TBL] [Abstract][Full Text] [Related]
9. Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit.
Curran ME; Platero S
Pharmacogenomics; 2011 Apr; 12(4):465-70. PubMed ID: 21521019
[TBL] [Abstract][Full Text] [Related]
10. Do companion diagnostics make economic sense for drug developers?
Agarwal A
N Biotechnol; 2012 Sep; 29(6):695-708. PubMed ID: 22575210
[TBL] [Abstract][Full Text] [Related]
11. Conference Scene: The healthcare reform act, comparative effectiveness research and personalized medicine.
Ofili E; Sproles D
Per Med; 2011 Mar; 8(2):133-135. PubMed ID: 29783400
[TBL] [Abstract][Full Text] [Related]
12. 10th annual drug discovery technology(®) europe and infotechpharma(®) conference.
Kiyani S; Quigley E; Schlachter A; Treadway A
Expert Opin Drug Discov; 2006 Jun; 1(1):91-4. PubMed ID: 23506035
[TBL] [Abstract][Full Text] [Related]
13. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.
Malentacchi F; Mancini I; Brandslund I; Vermeersch P; Schwab M; Marc J; van Schaik RH; Siest G; Theodorsson E; Pazzagli M; Di Resta C; ;
Clin Chem Lab Med; 2015 Jun; 53(7):981-8. PubMed ID: 25995323
[TBL] [Abstract][Full Text] [Related]
14. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.
Malentacchi F; Mancini I; Brandslund I; Vermeersch P; Schwab M; Marc J; van Schaik RH; Siest G; Theodorsson E; Pazzagli M; Di Resta C;
Drug Metab Pers Ther; 2015 Jun; 30(2):121-8. PubMed ID: 26036226
[TBL] [Abstract][Full Text] [Related]
15. Conference scene: UK pharmacogenetics and stratified medicine network.
Hall I
Pharmacogenomics; 2012 Jan; 13(1):19-20. PubMed ID: 22176620
[TBL] [Abstract][Full Text] [Related]
16. Companion diagnostics: emerging strategies and issues in pharmaceutical development.
Thomas J; Stratton E; Keppens M
Expert Rev Mol Diagn; 2012 Jul; 12(6):561-3. PubMed ID: 22845476
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers research in Europe: focus on personalized medicine.
Metodiev MV
Expert Rev Mol Diagn; 2011 Sep; 11(7):689-90. PubMed ID: 21902529
[TBL] [Abstract][Full Text] [Related]
18. [Current situation and challenges in companion diagnostics development].
Nishida M
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2529-34. PubMed ID: 25596043
[TBL] [Abstract][Full Text] [Related]
19. The Financial Times Global Pharmaceutical and Biotechnology Conference. Embracing Disruption for a New Era in Health (November 5-6, 2018 - London, UK.
Kibble A
Drugs Today (Barc); 2018 Dec; 54(12):747-752. PubMed ID: 30596393
[TBL] [Abstract][Full Text] [Related]
20. State of the industry for drug-diagnostic development: challenge and change on the path to precision medicine.
Milne CP; Cohen J; Chakravarthy R; Awatin J
Per Med; 2016 Jul; 13(4):337-345. PubMed ID: 29749814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
